A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine

Author: Jamali Abbas   Mahdavi Mehdi   Hassan Zuhair Muhammad   Sabahi Farzaneh   Farsani Mohammad Jazayeri   Bamdad Taravat   Soleimanjahi Hoorieh   Motazakker Morteza   Shahabi Shahram  

Publisher: Oxford University Press

ISSN: 1460-2377

Source: International Immunology, Vol.21, Iss.3, 2009-03, pp. : 217-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content